The US Food and Drug Administration has granted Fast Track designation to two Sanofi combination vaccine candidates to prevent influenza and COVID-19 infections in individuals 50 years of age and older. Both candidates combine two already licensed and authorized...
Mass cytometry analysis of B cells reveals distinct groups of activated and resting memory B cell populations. Credit: Nature Communications (2024). DOI: 10.1038/s41467-024-50997-4 Vaccines work by equipping our immune systems to fight an invading virus. When we get...
SILVER SPRING, Md., Aug. 22, 2024 /PRNewswire/ — Today, the U.S. Food and Drug Administration approved and granted emergency use authorization (EUA) for updated mRNA COVID-19 vaccines (2024-2025 formula) to include a monovalent (single) component that...
GSK on Wednesday announced it is restructuring an existing collaboration agreement with German biotech CureVac, focusing on their investigational mRNA vaccines for influenza and COVID-19 while withdrawing from other infectious disease projects. Under the amended...
Novavax’s updated vaccine will be available at vaccination centers across Taiwan GAITHERSBURG, Md., Dec. 18, 2023 /PRNewswire/ — Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced...
